Latest News and Press Releases
Want to stay updated on the latest news?
-
ANN ARBOR, Mich., Feb. 04, 2025 (GLOBE NEWSWIRE) -- ONL Therapeutics, Inc., a clinical-stage biopharmaceutical company developing novel therapies for protecting the vision of patients with retinal...
-
ANN ARBOR, Mich., Jan. 07, 2025 (GLOBE NEWSWIRE) -- ONL Therapeutics, Inc., a clinical-stage biopharmaceutical company developing novel therapies for protecting the vision of patients with retinal...
-
Dublin, Nov. 25, 2024 (GLOBE NEWSWIRE) -- The "Fundus Camera Market Global Forecast Report by Product Type, End-User, Countries and Company Analysis 2025-2033" report has been added to ...
-
Dublin, Nov. 15, 2024 (GLOBE NEWSWIRE) -- The "Saudi Arabia Eye Care Market, By Region, Competition, Forecast & Opportunities, 2019-2029F" report has been added to ResearchAndMarkets.com's...
-
Dublin, Nov. 14, 2024 (GLOBE NEWSWIRE) -- The "India Ophthalmoscope Market, By Region, Competition, Forecast & Opportunities, 2020-2030F" report has been added to ResearchAndMarkets.com's...
-
Dublin, Nov. 07, 2024 (GLOBE NEWSWIRE) -- The "Myopia and Presbyopia Treatment - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.The global market for...
-
Dublin, Nov. 05, 2024 (GLOBE NEWSWIRE) -- The "Ophthalmoscopes Market - Focused Insights 2024-2029" report has been added to ResearchAndMarkets.com's offering.The Ophthalmoscopes Market was valued...
-
ANN ARBOR, Mich., Sept. 13, 2024 (GLOBE NEWSWIRE) -- ONL Therapeutics, Inc., a clinical-stage biopharmaceutical company developing novel therapies for protecting the vision of patients with retinal...
-
ANN ARBOR, Mich., Sept. 10, 2024 (GLOBE NEWSWIRE) -- ONL Therapeutics, Inc., a clinical-stage biopharmaceutical company developing novel therapies for protecting the vision of patients with retinal...
-
Rockville, MD, Aug. 07, 2024 (GLOBE NEWSWIRE) -- As per a new research study released by Fact.MR, the global vitreoretinal surgery device market is estimated to be worth US$ 2.23 billion in 2024 and...